Osmosis Cuts Stake in Amgen Amid Broader Institutional Shift

Osmosis Investment Management UK Ltd has reduced its stake in Amgen Inc., selling off nearly a third of its shares during the second quarter. According to a recent filing with the Securities & Exchange Commission, Osmosis Investment Management UK Ltd now owns 32,649 shares of Amgen's stock, valued at approximately $11.8 million.

This move comes as part of a broader trend in which institutional investors have been adjusting their holdings in Amgen. Several other firms, including Dogwood Wealth Management LLC and Anfield Capital Management LLC, have increased their stakes in the company.

Despite this reduction, Osmosis Investment Management UK Ltd remains one of the largest shareholders of Amgen, with a stake that represents only 0.85% of the company's outstanding shares. The firm's decision to sell off some of its Amgen holdings may be motivated by a desire to diversify its portfolio or adjust to changes in market conditions.